BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31579913)

  • 1. Genetic variants in m6A modification genes are associated with colorectal cancer risk.
    Meng Y; Li S; Gu D; Xu K; Du M; Zhu L; Chu H; Zhang Z; Wu Y; Fu Z; Wang M
    Carcinogenesis; 2020 Mar; 41(1):8-17. PubMed ID: 31579913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of lncRNAs N
    Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ╬▓-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer.
    Song P; Feng L; Li J; Dai D; Zhu L; Wang C; Li J; Li L; Zhou Q; Shi R; Wang X; Jin H
    Mol Cancer; 2020 Aug; 19(1):129. PubMed ID: 32838807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANKLE1 N
    Tian J; Ying P; Ke J; Zhu Y; Yang Y; Gong Y; Zou D; Peng X; Yang N; Wang X; Mei S; Zhang Y; Wang C; Zhong R; Chang J; Miao X
    Int J Cancer; 2020 Jun; 146(12):3281-3293. PubMed ID: 31509622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
    Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
    Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress of N6-methyladenosine in colorectal cancer: A review.
    Lin Y; Shi H; Wu L; Ge L; Ma Z
    Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene signature and prognostic merit of M6a regulators in colorectal cancer.
    Zhang J; Cheng X; Wang J; Huang Y; Yuan J; Guo D
    Exp Biol Med (Maywood); 2020 Sep; 245(15):1344-1354. PubMed ID: 32605475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated N6-methyladenosine┬ámethylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease.
    Qin L; Min S; Shu L; Pan H; Zhong J; Guo J; Sun Q; Yan X; Chen C; Tang B; Xu Q
    Neurobiol Aging; 2020 Sep; 93():143.e9-143.e13. PubMed ID: 32371107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of common genetic variants in vitamin E-related pathway genes and colorectal cancer susceptibility.
    Zhang Q; Meng Y; Du M; Li S; Xin J; Ben S; Zhang Z; Gu D; Wang M
    Arch Toxicol; 2021 Jul; 95(7):2523-2532. PubMed ID: 34009442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
    Chen M; Wong CM
    Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.
    Qiao H; Liu L; Chen J; Shang B; Wang L
    Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.